Adaptive Biotechnologies
Yahoo Finance • 6 months ago
ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Cathie Wood, co-founder, CEO, and investment manager of the ARK Invest family of exchange-traded funds, regularly discloses her stock tra... Full story
Yahoo Finance • 6 months ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood makes it easy to keep tabs on her aggressive growth stock habits. The co-founder, CEO, and investment manager of the Ark Invest family of exchange-traded funds publishes her transactions at the end of every trading day. She bec... Full story
Yahoo Finance • 9 months ago
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript February 14, 2024 Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32. Adaptive Biotechnolog... Full story
Yahoo Finance • 11 months ago
16 Best Penny Stocks To Buy For 2024
In this article, we will take a detailed look at the16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break aft... Full story
Yahoo Finance • last year
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • last year
Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline
Data generated by Adaptive’s next-generation sequencing-based MRD assay will support the development and commercialization of investigational medicines for hematologic malignancies SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Bio... Full story
Yahoo Finance • last year
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023
SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story
Yahoo Finance • last year
Adaptive Announces Launch of Epic Integration for clonoSEQ®
SEATTLE, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnos... Full story
Yahoo Finance • last year
Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • last year
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023
SEATTLE, July 10, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • last year
11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical Stocks Under $10. The medical industry is one of t... Full story
Yahoo Finance • last year
Why Shares of Adaptive Biotechnologies Jumped This Week
Shares of Adaptive Biotechnologies (NASDAQ: ADPT) were up 15.7% for the week after climbing as high as 20.5%, according to data provided by S&P Global Market Intelligence. Adaptive said the Food and Drug Administration (FDA) had accepted t... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
SEATTLE, May 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into c... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology
SEATTLE, May 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to detect an... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnos... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023
SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference
SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
SEATTLE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • 2 years ago
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
SEATTLE, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story
Yahoo Finance • 2 years ago
Capella Space Raises $60M in Growth Equity from the United States Innovative Technology Fund to Expand Satellite Imaging Capacity and Meet Rapidly Growing Customer Demand
Leading provider of Earth observation data, utilizing Synthetic Aperture Radar (SAR), announces revenue tripled; brings on new CFO/COO, CISO and CHRO for next phase of growth SAN FRANCISCO, Jan. 10, 2023 /PRNewswire/ -- Capella Space, a l... Full story
